SOCIAL SIGNIFICANCE OF FAMILIAL HYPERCHOLESTEROLEMIA
Journal Title: Българско списание за обществено здраве (Bulgarian Journal of Public Health) - Year 2018, Vol 0, Issue 4
Abstract
Cardiovascular diseases are the most common debilitating condition worldwide. In the European Union, ischemic heart disease (a type of CVD due to atherosclerosis) remains the most common cause of death, causing approximately 1.8 million deaths (20% of all deaths) per year in Europe. Elevated LDL-C, the main component of total cholesterol, plays an important role in the development of atherosclerotic plaques and is the major cause of increased CV risk. Large-scale epidemiological studies have shown that elevated LDL-C levels are a major mechanism of the cardiovascular (CV) risk, demonstrating a direct connection between LDL-C levels and the incidence of a newly emerged IHD and IHD-related events, including death. FH is a hereditary disease caused by a variety of genetic mutations leading to significantly elevated LDL-C levels and resulting in 20-times higher lifelong risk of a premature CVD. Patients with FH may have several symptoms and risk factors, including family history of premature IHD, presence of early IHD as a separate case; elevated LDL-C levels; tendon xanthomas (cholesterol-rich deposits in the tendons of the hands, feet and heels); and corneal arc (lipid deposits on the cornea). There are 2 genetic options of FH: one is caused by the inheritance of the FH gene from one of the parents (HeFH) and the other is caused by the inheritance of the gene from the two parents (HoFH). HoFH is an extremely rare disease affecting approximately 1 in 1 million people worldwide and is therefore considered an extremely rare indication (orphan). By contrast, the calculated HeFH prevalence is 1 in 500 people worldwide. In patients with untreated FH, the risk of premature IHD is about 20 times higher. Untreated male patients have a 50% risk of a coronary event up to 50 years of age; untreated women have a 30% risk of a coronary event up to 60 years of age. As a result, FH patients need the most intense lipid-modifying treatment that they can tolerate in reasonable limits.
Authors and Affiliations
Svetoslav Tsenov, Evgeni Grigorov, Plamen Dimitrov
Keywords
Related Articles
- EP ID EP461407
- DOI -
- Views 67
- Downloads 0
RESEARCH OF THE CITIZENS’ATTITUDE IN THEIR USE OF PLANT FOOD SUPPLEMENTS IN BULGARIA
This publication presents the results of a research into consumers’ attitudes towards the use of teas. Materials and methods: A cross-sectional survey design with 400 individuals aged 18-80, who expressed willingness and...
ROLE OF THE AUDIENCE SEGMENTATION FOR THE HEALTH COMMUNICATION PROCESS
Health communication is a multifaceted and multidisciplinary approach to sharing health information and is an integral part of the programs of health promotion. Good knowledge of the audience allows the health message an...
ASSESSMENT OF THE MARKET FOR BIOLOGICAL PREPARATIONS, INCLUDED IN THE POSITIVE DRUG LIST (PDL), AND THE BUDGETARY IMPACT OF INTRODUCING A NEW PREPARATION
The article presented examines the usage, payment, market share and impact on the budget of the National Health Insurance Fund (NHIF), (the perspective of the payer) as well as analysis of pharmacological data, effective...
DESIGN AND METHODOLOGY OF NATIONAL SURVEY ON NUTRITION OF INFANTS AND CHILDREN UNDER 5 YEARS OF AGE AND FAMILY CHILD REARING in BULGARIA
Adequate nutrition of infants and young children is one of the factors that determine an optimal physical and psychological development and good health status. Prevention of nutritional deficiencies and nutritional statu...
HUMAN BIOMONITORING AND BIOMARKERS OF EXPOSURE
Assessment of the exposure to chemical substances is an essential element of the quantitative risk assessment. Traditionally, it is performed by measuring their concentrations in the air at the workplace, or in the envir...